Related Experiment Video

Updated: May 6, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

17.5K

Sox4you: a new player in C/EBPα leukemia

Tsz Kan Fung1, Anskar Yu Hung Leung, Chi Wai Eric So

  • 1Leukaemia and Stem Cell Biology Section, Division of Cancer Studies, Department of Haematological Medicine, King's College London, London SE5 9NU, UK.

Cancer Cell
|November 16, 2013
PubMed

Insights

Mutations in CEBPA are common in acute myeloid leukemia (AML). Researchers found SOX4 is a key mediator of these mutations, offering a new therapeutic target for AML.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • CEBPA mutations are frequent genetic alterations in acute myeloid leukemia (AML).
  • The precise mechanisms by which CEBPA mutations drive leukemogenesis are not fully understood.

Purpose of the Study:

  • To elucidate the role of SOX4 in the pathogenesis of AML associated with CEBPA mutations.
  • To identify potential therapeutic targets for AML driven by CEBPA abnormalities.

Main Methods:

  • Analysis of gene expression and mutation status in AML patient samples.
  • Functional studies using cell lines and preclinical models to assess the impact of SOX4.

Main Results:

  • SOX4 was identified as a direct transcriptional target of mutant C/EBPα.
  • SOX4 acts as a crucial mediator, promoting leukemogenesis in the context of CEBPA mutations.

Conclusions:

  • SOX4 is a key downstream effector of C/EBPα mutants in AML.
  • Targeting SOX4 represents a promising therapeutic strategy for AML patients with CEBPA mutations.

More Related Videos

Recombinant Retroviral Production and Infection of B Cells09:19

Recombinant Retroviral Production and Infection of B Cells

Published on: February 18, 2011

13.8K
In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)06:48

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

690

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.1K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.8K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
3.0K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
108
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K